Nizoral is an anti-dandruff shampoo from Kramer Laboratories that contains ketoconazole and is sold in North American and European retail.
Nizoral is a brand of Kramer Laboratories, Inc., headquartered in Fort Washington, US, which makes Nizoral Anti-Dandruff Shampoo with ketoconazole to control the fungal activity linked to dandruff. The product is sold through pharmacies, supermarkets and online platforms, mainly in North America and Europe, at a premium price point. Kramer Laboratories, a portfolio company of Avista Capital Partners and Dana Holdings, acquired Nizoral on June 21, 2018. The company plans new variations and expansion into Japan and South Korea by the end of 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in